Table 2 Summery of Mutations in LEPREL1, SLC39A5 and LRPAP1.

From: Mutational screening of SLC39A5, LEPREL1 and LRPAP1 in a cohort of 187 high myopia patients

Chr.position

Gene

Exon

Mutation

Status

Patient

Mutation

SIFT

PolyPhen2

PROVEAN

Mutation

Note

ExAC

Taster

Assessor

Chr12:56231524

SLC39A5

4

c.250C > T (p.Arg84Trp)

Het

HM_h16

DC (0.935)

D (0.004)

Pr.D (0.995)

N (−1.97)

L (1.61)

rs199681035

0.0001771

Chr12:56629399

SLC39A5

8

c.860C > T (p.Pro287Leu)

Het

HM_95

DC (0.995)

D (0.047)

B (0.231)

N (−0.57)

N (0.555)

Novel

0.0001895

Chr12:56630190

SLC39A5

9

c.956G > C (p.Arg319Thr)

Het

HM_71

P (0.283)

D (0.022)

B (0.174)

N (−0.84)

L (1.09)

Novel

Chr3:190120600

LEPREL1

1

c.132C > A (p.Phe44Leu)

Het

HM_101

DC (0.996)

T (0.191)

B (0.002)

N (−1.58)

L (1.59)

rs367659257

0.0001129

Chr3:189972991

LEPREL1

11

c.1582G > A (p.Ala528Thr)

Het

HM_68

DC (0.999)

D (0.014)

Pr.D (0.977)

D (−3.55)

M (2.83)

rs199877373

0.000132

Chr3:189681799

LEPREL1

14

c.1982A > G (p.Lys661Arg)

Het

HM_68

DC (1)

T (0.594)

B (0.000)

N (1.06)

N (−0.22)

Novel

3.30E-05

Chr4:3514801

LRPAP1

7

c.962 G > A (p.Arg321His)

Het

HM_h32

P (0.016)

T (0.17)

Pos.D (0.884)

N (−0.60)

M (2.2)

rs140947105

0.00015

  1. Notes: Het, heterozygous; Mutation taster (DC, disease-causing; P, polymorphism); SIFT (D, damaging; T, tolerated); PolyPhen2 (Pr.D, probably damaging; pos.D, possible damaging; B, benign); PROVEAN (D, deleterious; N, neutral); MutationAssessor (M, medium; L, low; N, neutral).